Pancreatic Cancer Non-resectable Clinical Trials

43 clinical trials for Pancreatic Cancer Non-resectable across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pancreatic Cancer Detection Consortium — RECRUITING
• EUS Procedures Using RIVOS™ EUS Access Device — RECRUITING
• Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer — RECRUITING · PHASE1
• Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer — RECRUITING · PHASE2
• Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer — RECRUITING · NA
• Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer — RECRUITING · PHASE2
• Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer — RECRUITING · PHASE2
• Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- — RECRUITING
• Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. — RECRUITING · NA
• Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer — RECRUITING · NA
• Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases — NOT_YET_RECRUITING
• EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) — SUSPENDED · NA
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1
• Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer — ACTIVE_NOT_RECRUITING
• Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE4
• Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer — ACTIVE_NOT_RECRUITING
• Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents — ACTIVE_NOT_RECRUITING · NA
• INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer — COMPLETED · PHASE2
• Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer — COMPLETED · PHASE3
• Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer — NOT_YET_RECRUITING · PHASE2
• Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. — NOT_YET_RECRUITING · PHASE1
• mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer — OTHER · PHASE1
• A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer — OTHER · PHASE1
• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — COMPLETED · PHASE3
• Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography — NOT_YET_RECRUITING
• Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer — COMPLETED · PHASE2
• Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer — NOT_YET_RECRUITING · PHASE4
• Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE2
• Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer — COMPLETED · PHASE2
• RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer — OTHER · PHASE1
• Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System — OTHER · NA
• PanDox: Targeted Doxorubicin in Pancreatic Tumours — WITHDRAWN · PHASE1
• PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT — NOT_YET_RECRUITING · NA
• Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer — OTHER · NA
• Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer — TERMINATED · PHASE4
• Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients — OTHER · NA
• Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma — OTHER · PHASE2
• Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer — OTHER · PHASE1
• I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer — OTHER · NA
• Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX — COMPLETED

Refine this search